The global Nedaplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Nedaplatin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nedaplatin API.
Report Scope
The Nedaplatin API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nedaplatin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nedaplatin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nanjing Hairun Pharmaceutical
Simcere
Qilu Pharma
Jilin Hengjin Pharmaceutical
Segment by Type
Purity ≥98%
Purity ≥99%
Segment by Application
Lung Cancer
Esophageal Cancer
Bladder Cancer
Testicular Cancer
Ovarian Cancer
Cervical Cancer
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nedaplatin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Nedaplatin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Nedaplatin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Nedaplatin API Market Overview
1.1 Product Definition
1.2 Nedaplatin API Segment by Type
1.2.1 Global Nedaplatin API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥98%
1.2.3 Purity ≥99%
1.3 Nedaplatin API Segment by Application
1.3.1 Global Nedaplatin API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Lung Cancer
1.3.3 Esophageal Cancer
1.3.4 Bladder Cancer
1.3.5 Testicular Cancer
1.3.6 Ovarian Cancer
1.3.7 Cervical Cancer
1.3.8 Other
1.4 Global Market Growth Prospects
1.4.1 Global Nedaplatin API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Nedaplatin API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Nedaplatin API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Nedaplatin API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nedaplatin API Production Market Share by Manufacturers (2019-2024)
2.2 Global Nedaplatin API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Nedaplatin API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Nedaplatin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Nedaplatin API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Nedaplatin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Nedaplatin API, Product Offered and Application
2.8 Global Key Manufacturers of Nedaplatin API, Date of Enter into This Industry
2.9 Nedaplatin API Market Competitive Situation and Trends
2.9.1 Nedaplatin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Nedaplatin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Nedaplatin API Production by Region
3.1 Global Nedaplatin API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Nedaplatin API Production Value by Region (2019-2030)
3.2.1 Global Nedaplatin API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Nedaplatin API by Region (2025-2030)
3.3 Global Nedaplatin API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Nedaplatin API Production by Region (2019-2030)
3.4.1 Global Nedaplatin API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Nedaplatin API by Region (2025-2030)
3.5 Global Nedaplatin API Market Price Analysis by Region (2019-2024)
3.6 Global Nedaplatin API Production and Value, Year-over-Year Growth
3.6.1 North America Nedaplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Nedaplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Nedaplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Nedaplatin API Production Value Estimates and Forecasts (2019-2030)
4 Nedaplatin API Consumption by Region
4.1 Global Nedaplatin API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Nedaplatin API Consumption by Region (2019-2030)
4.2.1 Global Nedaplatin API Consumption by Region (2019-2024)
4.2.2 Global Nedaplatin API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Nedaplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Nedaplatin API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nedaplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Nedaplatin API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Nedaplatin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Nedaplatin API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nedaplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Nedaplatin API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Nedaplatin API Production by Type (2019-2030)
5.1.1 Global Nedaplatin API Production by Type (2019-2024)
5.1.2 Global Nedaplatin API Production by Type (2025-2030)
5.1.3 Global Nedaplatin API Production Market Share by Type (2019-2030)
5.2 Global Nedaplatin API Production Value by Type (2019-2030)
5.2.1 Global Nedaplatin API Production Value by Type (2019-2024)
5.2.2 Global Nedaplatin API Production Value by Type (2025-2030)
5.2.3 Global Nedaplatin API Production Value Market Share by Type (2019-2030)
5.3 Global Nedaplatin API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Nedaplatin API Production by Application (2019-2030)
6.1.1 Global Nedaplatin API Production by Application (2019-2024)
6.1.2 Global Nedaplatin API Production by Application (2025-2030)
6.1.3 Global Nedaplatin API Production Market Share by Application (2019-2030)
6.2 Global Nedaplatin API Production Value by Application (2019-2030)
6.2.1 Global Nedaplatin API Production Value by Application (2019-2024)
6.2.2 Global Nedaplatin API Production Value by Application (2025-2030)
6.2.3 Global Nedaplatin API Production Value Market Share by Application (2019-2030)
6.3 Global Nedaplatin API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Nanjing Hairun Pharmaceutical
7.1.1 Nanjing Hairun Pharmaceutical Nedaplatin API Corporation Information
7.1.2 Nanjing Hairun Pharmaceutical Nedaplatin API Product Portfolio
7.1.3 Nanjing Hairun Pharmaceutical Nedaplatin API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Nanjing Hairun Pharmaceutical Main Business and Markets Served
7.1.5 Nanjing Hairun Pharmaceutical Recent Developments/Updates
7.2 Simcere
7.2.1 Simcere Nedaplatin API Corporation Information
7.2.2 Simcere Nedaplatin API Product Portfolio
7.2.3 Simcere Nedaplatin API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Simcere Main Business and Markets Served
7.2.5 Simcere Recent Developments/Updates
7.3 Qilu Pharma
7.3.1 Qilu Pharma Nedaplatin API Corporation Information
7.3.2 Qilu Pharma Nedaplatin API Product Portfolio
7.3.3 Qilu Pharma Nedaplatin API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Qilu Pharma Main Business and Markets Served
7.3.5 Qilu Pharma Recent Developments/Updates
7.4 Jilin Hengjin Pharmaceutical
7.4.1 Jilin Hengjin Pharmaceutical Nedaplatin API Corporation Information
7.4.2 Jilin Hengjin Pharmaceutical Nedaplatin API Product Portfolio
7.4.3 Jilin Hengjin Pharmaceutical Nedaplatin API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Jilin Hengjin Pharmaceutical Main Business and Markets Served
7.4.5 Jilin Hengjin Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nedaplatin API Industry Chain Analysis
8.2 Nedaplatin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nedaplatin API Production Mode & Process
8.4 Nedaplatin API Sales and Marketing
8.4.1 Nedaplatin API Sales Channels
8.4.2 Nedaplatin API Distributors
8.5 Nedaplatin API Customers
9 Nedaplatin API Market Dynamics
9.1 Nedaplatin API Industry Trends
9.2 Nedaplatin API Market Drivers
9.3 Nedaplatin API Market Challenges
9.4 Nedaplatin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Nanjing Hairun Pharmaceutical
Simcere
Qilu Pharma
Jilin Hengjin Pharmaceutical
Ìý
Ìý
*If Applicable.
